STAT3 and in situ carcinoma: In an orthotopic mouse bladder cancer model, STAT3-transgenic mice, compared with the wild-type counterparts, developed invasive cancer directly from carcinoma in situ (CIS) in a shorter time, bypassing the noninvasive papillary tumor stage [13].